BML Capital Management, LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001616824
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2026 · 18 positions · Total reported value $176.05M · Top-10 concentration 93.3% · Updated 2026-10-24
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
Turnover: 38.1% · 3 new · 4 cut · 1 exited
Active Share (vs S&P 500): 99.2% · vs QQQ: 99.3% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): +2.1% · vs SPY -0.0% · Prev Value $176.05M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -15.2% · vs SPY -17.3% · Latest Value $187.62M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q2 2026 13F filing, BML Capital Management, LLC disclosed 18 equity positions with a combined reported value of $176.05M. The filing implies a focused portfolio: its ten largest positions account for 93.3% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2026 were ACRS ($63.35M), AVIR ($32.33M), ENGN ($11.54M). By sector, the heaviest allocations are Health Care 80.1%, Consumer Discretionary 13.3%. Versus the prior quarter, allocation shifted toward Consumer Staples (+4.4pp) and away from Health Care (-1.8pp), Other (-3.4pp).
Versus the prior quarter, BML Capital Management, LLC opened 3 new positions, trimmed 4 and fully exited 1, a turnover rate of 38.1% of positions. The portfolio's overlap with the prior quarter was 79% of names.
The largest new positions opened in Q2 2026 were ENGN ($11.54M), CORZ ($298.00K), TSLA ($270.00K).
Of the 1 positions fully exited versus the prior quarter, the largest were KZR ($5.35M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2026)
Fully Exited (vs previous quarter)
- KZR KEZAR LIFE SCIENCES INC · prev qtr: $5.35M
Insider Transactions (Form 4)
Latest BML Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
BML Capital Management, LLC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 18 positions worth $176.05M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 18 positions · $176.05M reported value (Q2 2026)
- Top 10 holdings = 93.3% of reported value
- Largest position: ACRS (ACLARIS THERAPEUTICS INC) at 36.0%
- Average position size: $9.78M
Sector Tilt
- Health Care 80.1%
- Consumer Discretionary 13.3%
- Consumer Staples 6.2%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 3 new, 4 added, 3 reduced, 1 exited
- 8 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
11.97M | $63.35M | 35.98% | Reduce | |
| 2 |
|
6.95M | $32.33M | 18.36% | Reduce | |
| 3 |
|
6.67M | $11.54M | 6.55% | New | |
| 4 |
|
465.00K | $10.98M | 6.24% | Add | |
| 5 |
|
2.52M | $10.89M | 6.18% | Add | |
| 6 |
|
172.50K | $9.12M | 5.18% | Add | |
| 7 |
|
2.15M | $9.03M | 5.13% | Hold | |
| 8 |
|
5.33M | $7.14M | 4.06% | Hold | |
| 9 |
|
645.60K | $4.96M | 2.82% | Hold | |
| 10 |
|
37.50K | $4.90M | 2.78% | Hold | |
| 11 |
|
866.27K | $4.17M | 2.37% | Reduce | |
| 12 |
|
154.96K | $2.38M | 1.35% | Hold | |
| 13 |
|
1.55M | $1.76M | 1.00% | Hold | |
| 14 |
|
573.29K | $1.36M | 0.78% | Add | |
| 15 |
|
200.73K | $1.18M | 0.67% | Hold | |
| 16 |
|
335 | $386.09K | 0.22% | Hold | |
| 17 |
|
800 | $298.00K | 0.17% | New | |
| 18 |
|
375 | $270.00K | 0.15% | New | |
FAQ
What did BML Capital Management, LLC buy in 2026-Q2?
In its 2026-Q2 13F filing, BML Capital Management, LLC reported 18 equity positions worth $176.05M in aggregate; its largest disclosed positions were ACRS ($63.35M), AVIR ($32.33M), ENGN ($11.54M).
How large is BML Capital Management, LLC's portfolio?
BML Capital Management, LLC reported $176.05M of long equity holdings across 18 positions as of 2026-Q2. Top-10 holdings account for 93.3% of reported value.
What is BML Capital Management, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.